Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 1716341, 10 pages
http://dx.doi.org/10.1155/2016/1716341
Review Article

Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy

1International Clinical Research Center, St. Anne’s University Hospital, Masaryk University, Kamenice 5/A7, 625 00 Brno, Czech Republic
2Institute of Molecular Biology and Biophysics, Novosibirsk, Russia
3Oncology and Pathology Group, Institut de Recerca Hospital Vall d’Hebron, Passeig Vall d’Hebron 119-129, 08035 Barcelona, Spain

Received 19 June 2015; Revised 24 August 2015; Accepted 25 August 2015

Academic Editor: Amit Tyagi

Copyright © 2016 Alex Lyakhovich and Matilde E. Lleonart. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Plaks, N. Kong, and Z. Werb, “The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?” Cell Stem Cell, vol. 16, no. 3, pp. 225–238, 2015. View at Publisher · View at Google Scholar
  2. J. A. Leal, A. Feliciano, and M. E. Lleonart, “Stem cell MicroRNAs in senescence and immortalization: novel players in cancer therapy,” Medicinal Research Reviews, vol. 33, no. 1, pp. 112–138, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Mitra, L. Mishra, and S. Li, “EMT, CTCs and CSCs in tumor relapse and drug-resistance,” Oncotarget, vol. 6, no. 13, pp. 10697–10711, 2015. View at Google Scholar
  4. H. T. Hassan, “c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications,” Leukemia Research, vol. 33, no. 1, pp. 5–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Studer, E. Vera, and D. Cornacchia, “Programming and reprogramming cellular age in the era of induced pluripotency,” Cell Stem Cell, vol. 16, no. 6, pp. 591–600, 2015. View at Publisher · View at Google Scholar
  6. S. D. Mertins, “Cancer stem cells: a systems biology view of their role in prognosis and therapy,” Anti-Cancer Drugs, vol. 25, no. 4, pp. 353–367, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Moulder, “Intrinsic resistance to chemotherapy in breast cancer,” Women's Health, vol. 6, no. 6, pp. 821–830, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Cojoc, K. Mäbert, M. H. Muders, and A. Dubrovska, “A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms,” Seminars in Cancer Biology, vol. 31, pp. 16–27, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Ding, C. Li, N. Cheng, X. Cui, X. Xu, and G. Zhou, “Redox regulation in cancer stem cells,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 750798, 11 pages, 2015. View at Publisher · View at Google Scholar
  10. V. Sosa, T. Moliné, R. Somoza, R. Paciucci, H. Kondoh, and M. E. LLeonart, “Oxidative stress and cancer: an overview,” Ageing Research Reviews, vol. 12, no. 1, pp. 376–390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. C. Benz and C. Yau, “Ageing, oxidative stress and cancer: paradigms in parallax,” Nature Reviews Cancer, vol. 8, no. 11, pp. 875–879, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Wang and J. Yi, “Cancer cell killing via ROS: to increase or decrease, that is a question,” Cancer Biology and Therapy, vol. 7, no. 12, pp. 1875–1884, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Colak and J. P. Medema, “Cancer stem cells—important players in tumor therapy resistance,” FEBS Journal, vol. 281, no. 21, pp. 4779–4791, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Dean, “ABC transporters, drug resistance, and cancer stem cells,” Journal of Mammary Gland Biology and Neoplasia, vol. 14, no. 1, pp. 3–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Cui, A. J. Zhang, M. Chen, and J. J. Liu, “ABC transporter inhibitors in reversing multidrug resistance to chemotherapy,” Current Drug Targets, vol. 16, no. 14, 2015. View at Publisher · View at Google Scholar
  16. A. Shervington and C. Lu, “Expression of multidrug resistance genes in normal and cancer stem cells,” Cancer Investigation, vol. 26, no. 5, pp. 535–542, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Dean, T. Fojo, and S. Bates, “Tumour stem cells and drug resistance,” Nature Reviews Cancer, vol. 5, no. 4, pp. 275–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Liesa, W. Qiu, and O. S. Shirihai, “Mitochondrial ABC transporters function: the role of ABCB10 (ABC-me) as a novel player in cellular handling of reactive oxygen species,” Biochimica et Biophysica Acta, vol. 1823, no. 10, pp. 1945–1957, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. López-Erauskin, J. Galino, M. Ruiz et al., “Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy,” Human Molecular Genetics, vol. 22, no. 16, pp. 3296–3305, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. P. Fahrenbach, D. Stoller, G. Kim et al., “Abcc9 is required for the transition to oxidative metabolism in the newborn heart,” The FASEB Journal, vol. 28, no. 7, pp. 2804–2815, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Yang, J. Yang, L. Li et al., “PAAT, a novel ATPase and trans-regulator of mitochondrial ABC transporters, is critically involved in the maintenance of mitochondrial homeostasis,” The FASEB Journal, vol. 28, no. 11, pp. 4821–4834, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Lou, L. Zhu, H. Ding, H.-Y. Dai, and G.-M. Zou, “Aberrant expression of redox protein Ape1 in colon cancer stem cells,” Oncology Letters, vol. 7, no. 4, pp. 1078–1082, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Riganti, B. Rolando, J. Kopecka et al., “Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance,” Molecular Pharmaceutics, vol. 10, no. 1, pp. 161–174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. Z. Wang, Y. Li, and F. H. Sarkar, “Signaling mechanism(S) of reactive oxygen species in epithelial-mesenchymal transition reminiscent of cancer stem cells in tumor progression,” Current Stem Cell Research & Therapy, vol. 5, no. 1, pp. 74–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Bao, A. S. Azmi, Y. Li et al., “Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness,” Current Stem Cell Research and Therapy, vol. 9, no. 1, pp. 22–35, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. J.-N. Zhou, Q. Zeng, H.-Y. Wang et al., “MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4,” Hepatology, vol. 62, no. 3, pp. 801–815, 2015. View at Publisher · View at Google Scholar
  27. J. R. Kirshner, S. He, V. Balasubramanyam et al., “Elesclomol induces cancer cell apoptosis through oxidative stress,” Molecular Cancer Therapeutics, vol. 7, no. 8, pp. 2319–2327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Qu, J. Wang, M.-S. Sim et al., “Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells,” Breast Cancer Research and Treatment, vol. 121, no. 2, pp. 311–321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Leskovar, H. Wegele, N. D. Werbeck, J. Buchner, and J. Reinstein, “The ATPase cycle of the mitochondrial Hsp90 analog trap1,” The Journal of Biological Chemistry, vol. 283, no. 17, pp. 11677–11688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. W. Pridgeon, J. A. Olzmann, L.-S. Chin, and L. Li, “PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1,” PLoS Biology, vol. 5, no. 7, article e172, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. B. H. Kang and D. C. Altieri, “Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones,” Oncogene, vol. 28, no. 42, pp. 3681–3688, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Rico-Bautista, C.-C. Yang, L. Lu, G. P. Roth, and D. A. Wolf, “Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells,” BMC Biology, vol. 8, article 153, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. C. Maiuri, A. Criollo, and G. Kroemer, “Crosstalk between apoptosis and autophagy within the Beclin 1 interactome,” The EMBO Journal, vol. 29, no. 3, pp. 515–516, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. Y.-Y. Wang, Y.-X. Yang, H. Zhe, Z.-X. He, and S.-F. Zhou, “Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties,” Drug Design, Development and Therapy, vol. 8, pp. 2075–2088, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Fu, H. Chang, X. Peng et al., “Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway,” PLoS ONE, vol. 9, no. 7, Article ID e102535, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Kaushik, A. Venugopal, P. Ramamoorthy et al., “Honokiol inhibits melanoma stem cells by targeting notch signaling,” Molecular Carcinogenesis, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. D. S. Choi, E. Blanco, Y.-S. Kim et al., “Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1,” Stem Cells, vol. 32, no. 9, pp. 2309–2323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Del Bufalo, M. Desideri, T. De Luca et al., “Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer,” Molecular Cancer, vol. 13, no. 1, article 230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. O. Zitka, S. Skalickova, J. Gumulec et al., “Redox status expressed as GSH:GSSG ratio as a marker for oxidative stress in paediatric tumour patients,” Oncology Letters, vol. 4, no. 6, pp. 1247–1253, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. R. Jangamreddy, S. Ghavami, J. Grabarek et al., “Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells,” Biochimica et Biophysica Acta, vol. 1833, no. 9, pp. 2057–2069, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. D. G. Tang, L. Li, Z. Zhu et al., “BMD188, a novel hydroxamic acid compound, demonstrates potent anti- prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases,” Pathology and Oncology Research, vol. 4, no. 3, pp. 179–190, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Xu, E. Tian, H. Tang, C. Liu, and Q. Wang, “Proteomic analysis of gossypol induces necrosis in multiple myeloma cells,” BioMed Research International, vol. 2014, Article ID 839232, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Hernlund, L. S. Ihrlund, O. Khan et al., “Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir,” International Journal of Cancer, vol. 123, no. 2, pp. 476–483, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Xing, S. Li, X. Ge et al., “The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo,” Oral Oncology, vol. 44, no. 10, pp. 963–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. H. M. Kim, N. Haraguchi, H. Ishii et al., “Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon,” Annals of Surgical Oncology, vol. 19, no. 3, pp. S539–S548, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Nishikawa, H. Ishii, N. Haraguchi et al., “Genotoxic therapy stimulates error-prone DNA repair in dormant hepatocellular cancer stem cells,” Experimental and Therapeutic Medicine, vol. 3, no. 6, pp. 959–962, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Liu, X. Yuan, Z. Zeng et al., “Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma,” Molecular Cancer, vol. 5, article 67, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Daniele, B. Costa, E. Zappelli et al., “Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells,” Scientific Reports, vol. 5, article 9956, 2015. View at Publisher · View at Google Scholar
  49. B. N. Singh, D. Kumar, S. Shankar, and R. K. Srivastava, “Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells,” Biochemical Pharmacology, vol. 84, no. 9, pp. 1154–1163, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Zhu, H. Wang, Y. Fan et al., “Targeting the NF-E2-related factor 2 pathway: a novel strategy for glioblastoma (Review),” Oncology Reports, vol. 32, no. 2, pp. 443–450, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Murakami and H. Motohashi, “Roles of NRF2 in cell proliferation and differentiation,” Free Radical Biology & Medicine, 2015. View at Publisher · View at Google Scholar
  52. I. G. Ryoo, B. H. Choi, and M. K. Kwak, “Activation of NRF2 by p62 and proteasome reduction in sphere-forming breast carcinoma cells,” Oncotarget, vol. 6, no. 10, pp. 8167–8184, 2015. View at Google Scholar
  53. C. A. Del Vecchio, Y. Feng, E. S. Sokol et al., “De-differentiation confers multidrug resistance via noncanonical PERK-Nrf2 signaling,” PLoS Biology, vol. 12, no. 9, Article ID e1001945, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Mizushima and M. Komatsu, “Autophagy: renovation of cells and tissues,” Cell, vol. 147, no. 4, pp. 728–741, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Fuchs and H. Steller, “Live to die another way: modes of programmed cell death and the signals emanating from dying cells,” Nature Reviews Molecular Cell Biology, vol. 16, no. 6, pp. 329–344, 2015. View at Publisher · View at Google Scholar
  56. S. Z. Lu and D. D. Harrison-Findik, “Autophagy and cancer,” World Journal of Biological Chemistry, vol. 4, no. 3, pp. 64–70, 2013. View at Google Scholar
  57. H. Zhu, D. Wang, Y. Liu et al., “Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells,” Cancer Cell International, vol. 13, no. 1, article 119, 2013. View at Publisher · View at Google Scholar
  58. U. E. Martinez-Outschoorn, C. Trimmer, Z. Lin et al., “Autophagy in cancer associated fibroblasts promotes tumor cell survival: role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment,” Cell Cycle, vol. 9, no. 17, pp. 3515–3533, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. Y.-J. Song, S.-S. Zhang, X.-L. Guo et al., “Autophagy contributes to the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment,” Cancer Letters, vol. 339, no. 1, pp. 70–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Yu, C. Gu, D. Zhong et al., “Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance,” Cancer Letters, vol. 355, no. 1, pp. 34–45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Yu, C. Gu, D. Zhong et al., “Autophagy contributes to the enrichment and survival of colorectal cancer stem cells under oxaliplatin treatment,” Cancer Letters, vol. 361, pp. 128–136, 2015. View at Google Scholar
  62. J. Zhou, C. Xi, W. Wang et al., “Autophagy plays an important role in triptolide-induced apoptosis in cardiomyocytes,” Toxicology Letters, vol. 236, pp. 168–183, 2015. View at Google Scholar
  63. A. Viale, P. Pettazzoni, C. A. Lyssiotis et al., “Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function,” Nature, vol. 514, no. 7524, pp. 628–632, 2014. View at Publisher · View at Google Scholar
  64. H.-M. Zhang and Y. Zhang, “Melatonin: a well-documented antioxidant with conditional pro-oxidant actions,” Journal of Pineal Research, vol. 57, no. 2, pp. 131–146, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. V. Martín, A. M. Sanchez-Sanchez, N. Puente-Moncada et al., “Involvement of autophagy in melatonin-induced cytotoxicity in glioma-initiating cells,” Journal of Pineal Research, vol. 57, pp. 308–316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. R. Ojha, V. Jha, S. K. Singh, and S. Bhattacharyya, “Autophagy inhibition suppresses the tumorigenic potential of cancer stem cell enriched side population in bladder cancer,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1842, no. 11, pp. 2073–2086, 2014. View at Publisher · View at Google Scholar · View at Scopus
  67. P. B. Gupta, T. T. Onder, G. Jiang et al., “Identification of selective inhibitors of cancer stem cells by high-throughput screening,” Cell, vol. 138, no. 4, pp. 645–659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. J. R. Jangamreddy, M. V. Jain, A. L. Hallbeck et al., “Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death,” Oncotarget, vol. 6, no. 12, pp. 10134–10145, 2015. View at Google Scholar
  69. L.-Q. Zhu, Y.-F. Zhen, Y. Zhang, Z.-X. Guo, J. Dai, and X.-D. Wang, “Salinomycin activates AMP-activated protein kinase-dependent autophagy in cultured osteoblastoma cells: a negative regulator against cell apoptosis,” PLoS ONE, vol. 8, no. 12, Article ID e84175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. J.-H. Cheong, E. S. Park, J. Liang et al., “Dual inhibition of tumor energy pathway by 2-deoxyglucose and metformin is effective against a broad spectrum of preclinical cancer models,” Molecular Cancer Therapeutics, vol. 10, no. 12, pp. 2350–2362, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. Z. Wang, P. Liu, Q. Chen et al., “Targeting AMPK signaling pathway to overcome drug resistance for cancer therapy,” Current Drug Targets, vol. 16, no. 14, pp. 1–16, 2015. View at Publisher · View at Google Scholar
  72. G. W. Dorn and R. N. Kitsis, “The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble,” Circulation Research, vol. 116, no. 1, pp. 167–182, 2015. View at Publisher · View at Google Scholar · View at Scopus
  73. M. Frank, S. Duvezin-Caubet, S. Koob et al., “Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner,” Biochimica et Biophysica Acta: Molecular Cell Research, vol. 1823, no. 12, pp. 2297–2310, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. I. Tanida, “Autophagosome formation and molecular mechanism of autophagy,” Antioxidants & Redox Signaling, vol. 14, no. 11, pp. 2201–2214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. S. M. Houten, S. Denis, H. Te Brinke et al., “Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia,” Human Molecular Genetics, vol. 23, no. 18, pp. 5009–5016, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. M. L. Marino, S. Fais, M. Djavaheri-Mergny et al., “Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells,” Cell Death and Disease, vol. 1, no. 10, article e87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. G. Lin, D. K. Hill, G. Andrejeva et al., “Dichloroacetate induces autophagy in colorectal cancer cells and tumours,” British Journal of Cancer, vol. 111, no. 2, pp. 375–385, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. T. Sawa, H. Ihara, T. Ida, S. Fujii, M. Nishida, and T. Akaike, “Formation, signaling functions, and metabolisms of nitrated cyclic nucleotide,” Nitric Oxide, vol. 34, pp. 10–18, 2013. View at Publisher · View at Google Scholar
  79. S. Saeidnia and M. Abdollahi, “Toxicological and pharmacological concerns on oxidative stress and related diseases,” Toxicology and Applied Pharmacology, vol. 273, no. 3, pp. 442–455, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. X. Wang, S. Peralta, and C. T. Moraes, “Mitochondrial alterations during carcinogenesis: a review of metabolic transformation and targets for anticancer treatments,” Advances in Cancer Research, vol. 119, pp. 127–160, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Lyakhovich and D. Graifer, “Mitochondria-mediated oxidative stress: old target for new drugs,” Current Medicinal Chemistry, vol. 22, no. 26, pp. 3040–3053, 2015. View at Publisher · View at Google Scholar
  82. G. Pagano, P. Shyamsunder, R. S. Verma, and A. Lyakhovich, “Damaged mitochondria in Fanconi anemia—an isolated event or a general phenomenon?” Oncoscience, vol. 1, no. 4, pp. 287–295, 2014. View at Google Scholar
  83. S. Colak, C. D. Zimberlin, E. Fessler et al., “Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells,” Cell Death and Differentiation, vol. 21, no. 7, pp. 1170–1177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Janiszewska, M. L. Suvà, N. Riggi et al., “Imp2 controls oxidative phosphorylation and is crucial for preservin glioblastoma cancer stem cells,” Genes & Development, vol. 26, no. 17, pp. 1926–1944, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. P. Tokarz, K. Kaarniranta, and J. Blasiak, “Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD),” Biogerontology, vol. 14, no. 5, pp. 461–482, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Lu and A. Holmgren, “The thioredoxin antioxidant system,” Free Radical Biology and Medicine, vol. 66, pp. 75–87, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Yee, W. Yang, and S. Hekimi, “The intrinsic apoptosis pathway mediates the pro-longevity response to mitochondrial ROS in C elegans,” Cell, vol. 157, no. 4, pp. 897–909, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Abdal Dayem, H.-Y. Choi, J.-H. Kim, and S.-G. Cho, “Role of oxidative stress in stem, cancer, and cancer stem cells,” Cancers, vol. 2, no. 2, pp. 859–884, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. K. Wang, T. Zhang, Q. Dong, E. C. Nice, C. Huang, and Y. Wei, “Redox homeostasis: the linchpin in stem cell self-renewal and differentiation,” Cell Death & Disease, vol. 4, no. 3, article e537, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. X. Shi, Y. Zhang, J. Zheng, and J. Pan, “Reactive oxygen species in cancer stem cells,” Antioxidants and Redox Signaling, vol. 16, no. 11, pp. 1215–1228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. X.-Q. Ye, Q. Li, G.-H. Wang et al., “Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells,” International Journal of Cancer, vol. 129, no. 4, pp. 820–831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. Y.-A. Shen, C.-Y. Wang, Y.-T. Hsieh, Y.-J. Chen, and Y.-H. Wei, “Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma,” Cell Cycle, vol. 14, no. 1, pp. 86–98, 2015. View at Publisher · View at Google Scholar
  93. J. S. Moreb, “Aldehyde dehydrogenase as a marker for stem cells,” Current Stem Cell Research and Therapy, vol. 3, no. 4, pp. 237–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. K. Honoki, H. Fujii, A. Kubo et al., “Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance,” Oncology Reports, vol. 24, no. 2, pp. 501–505, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. F. Jiang, Q. Qi, A. Khanna et al., “Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer,” Molecular Cancer Research, vol. 7, no. 3, pp. 330–338, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. T. Tanei, K. Morimoto, K. Shimazu et al., “Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential paclitaxel and epirubicin-based chemotherapy for breast cancers,” Clinical Cancer Research, vol. 15, no. 12, pp. 4234–4241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. D. Raha, T. R. Wilson, J. Peng et al., “The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation,” Cancer Research, vol. 74, no. 13, pp. 3579–3590, 2014. View at Publisher · View at Google Scholar · View at Scopus
  98. M. G. Cipolleschi, I. Marzi, R. Santini et al., “Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets,” Cell Cycle, vol. 13, no. 2, pp. 268–278, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. S. G. Rhee, “Cell signaling: H2O2, a necessary evil for cell signaling,” Science, vol. 312, no. 5782, pp. 1882–1883, 2006. View at Google Scholar
  100. Y. Zhao, R. Li, W. Xia et al., “Bid integrates intrinsic and extrinsic signaling in apoptosis induced by α-tocopheryl succinate in human gastric carcinoma cells,” Cancer Letters, vol. 288, no. 1, pp. 42–49, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. L.-F. Dong, P. Low, J. C. Dyason et al., “Alpha-Tocopheryl succinate induces apoptosis by targeting ubiquinone-binding sites in mitochondrial respiratory complex II,” Oncogene, vol. 27, no. 31, pp. 4324–4335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. V. Gogvadze, E. Norberg, S. Orrenius, and B. Zhivotovsky, “Involvement of Ca2+ and ROS in α-tocopheryl succinate-induced mitochondrial permeabilization,” International Journal of Cancer, vol. 127, no. 8, pp. 1823–1832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. D. Chandra, G. Choy, and D. G. Tang, “Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3,” The Journal of Biological Chemistry, vol. 282, no. 43, pp. 31289–31301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. E. Hulleman, K. M. Kazemier, A. Holleman et al., “Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells,” Blood, vol. 113, no. 9, pp. 2014–2021, 2009. View at Publisher · View at Google Scholar · View at Scopus
  105. K. Sadahira, M. Sagawa, T. Nakazato et al., “Gossypol induces apoptosis in multiple myeloma cells by inhibition of interleukin-6 signaling and Bcl-2/Mcl-1 pathway,” International Journal of Oncology, vol. 45, no. 6, pp. 2278–2286, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. Z. Ni, X. Dai, B. Wang et al., “Natural Bcl-2 inhibitor (-)-gossypol induces protective autophagy via reactive oxygen species-high mobility group box 1 pathway in Burkitt lymphoma,” Leukemia & Lymphoma, vol. 54, no. 10, pp. 2263–2268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. P. Cheng, Z. Ni, X. Dai et al., “The novel BH-3 mimetic apogossypolone induces Beclin-1- and ROS-mediated autophagy in human hepatocellular carcinoma cells,” Cell Death and Disease, vol. 4, article e598, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. S. Legrand-Poels, N. Esser, L. L'Homme, A. Scheen, N. Paquot, and J. Piette, “Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes,” Biochemical Pharmacology, vol. 92, no. 1, pp. 131–141, 2014. View at Publisher · View at Google Scholar · View at Scopus
  109. Z. Luo, L. Yu, F. Yang et al., “Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase,” Metallomics, vol. 6, no. 8, pp. 1480–1490, 2014. View at Publisher · View at Google Scholar · View at Scopus
  110. D. Y. Alakhova and A. V. Kabanov, “Pluronics and MDR reversal: an update,” Molecular Pharmaceutics, vol. 11, no. 8, pp. 2566–2578, 2014. View at Publisher · View at Google Scholar · View at Scopus